Assessment of the metabolic tolerance in postmenopausal women over a 1-year period of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone

This double-blind, randomized, multi-center study compared the metabolic tolerance of a combined formulation containing estradiol (E2) and trimegestone (TMG) with a standard hormone replacement therapy (HRT) containing estradiol valerate (EV) and norgestrel (NG). Blood lipids, glucose and fibrinogen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gynecological endocrinology 2002-04, Vol.16 (2), p.155-162
Hauptverfasser:	MEUWISSEN, J. H. J. M, BEIJERS-DE BIE, L, DE VILLIERS, T. J, VIHTAMAKI, T, TUIMALA, R, SISELES, N, MAGARIL, C, THE, H. S, HOUBEN, P. W. H, MURGA, M, SPIELMANN, D
Format:	Artikel
Sprache:	eng
Schlagworte:	Apolipoprotein A-I - blood Apolipoproteins B - blood Biological and medical sciences Blood Glucose - analysis Cholesterol - blood Cholesterol, HDL - blood Cholesterol, LDL - blood Double-Blind Method Estradiol - administration & dosage Estradiol - analogs & derivatives Estrogen Replacement Therapy Female Fibrinogen - analysis Gynecology. Andrology. Obstetrics Hormones. Endocrine system Humans Lipids - blood Lipoprotein(a) - blood Lipoproteins, HDL - blood Lipoproteins, HDL2 Lipoproteins, HDL3 Management. Prenatal diagnosis Medical sciences Middle Aged Norgestrel - administration & dosage Pharmacology. Drug treatments Postmenopause Pregnancy. Fetus. Placenta Promegestone - administration & dosage Promegestone - analogs & derivatives
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!